109 related articles for article (PubMed ID: 32045604)
1. Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood.
Macías-Triana L; Romero-Cordero K; Tatum-Kuri A; Vera-Barrón A; Millán-Aldaco D; Arankowsky-Sandoval G; Piomelli D; Murillo-Rodríguez E
Eur J Pharmacol; 2020 May; 874():172911. PubMed ID: 32045604
[TBL] [Abstract][Full Text] [Related]
2. Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice.
Frontera JL; Gonzalez Pini VM; Messore FL; Brusco A
Neuropharmacology; 2018 Jul; 137():268-274. PubMed ID: 29778010
[TBL] [Abstract][Full Text] [Related]
3. Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence.
Murillo-Rodríguez E; Millán-Aldaco D; Cicconcelli D; Giorgetti V; Arankowsky-Sandoval G; Alcaraz-Silva J; Imperatori C; Machado S; Budde H; Torterolo P
Psychopharmacology (Berl); 2021 Jun; 238(6):1437-1447. PubMed ID: 33635384
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.
Moranta D; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):61-72. PubMed ID: 18709357
[TBL] [Abstract][Full Text] [Related]
5. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM; Aronne MP; Caltana L; Brusco AH
J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood.
Pushkin AN; Eugene AJ; Lallai V; Torres-Mendoza A; Fowler JP; Chen E; Fowler CD
PLoS One; 2019; 14(1):e0211346. PubMed ID: 30703155
[TBL] [Abstract][Full Text] [Related]
10. In utero cannabinoid exposure alters breathing and the response to hypoxia in newborn mice.
Tree KC; Scotto di Perretolo M; Peyronnet J; Cayetanot F
Eur J Neurosci; 2014 Jul; 40(1):2196-204. PubMed ID: 24717006
[TBL] [Abstract][Full Text] [Related]
11. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period.
Rudenko V; Rafiuddin A; Leheste JR; Friedman LK
Pharmacol Biochem Behav; 2012 Jan; 100(3):474-84. PubMed ID: 22019959
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine.
Scherma M; Qvist JS; Asok A; Huang SC; Masia P; Deidda M; Wei YB; Soni RK; Fratta W; Fadda P; Kandel ER; Kandel DB; Melas PA
Proc Natl Acad Sci U S A; 2020 May; 117(18):9991-10002. PubMed ID: 32312805
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
17. Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
Nallapaneni A; Liu J; Karanth S; Pope C
Toxicology; 2006 Oct; 227(1-2):173-83. PubMed ID: 16956707
[TBL] [Abstract][Full Text] [Related]
18. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
19. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
20. Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons.
Papanastassiou AM; Fields HL; Meng ID
Pain; 2004 Feb; 107(3):267-275. PubMed ID: 14736589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]